Click on, or paste the following link into your web browser, to view the associated PDF document
http://www.rns-pdf.londonstockexchange.com/rns/4912I_1-2022-4-15.pdf
|
|
|
|
|
Commercial International Bank (Egypt) S.A.E. |
||||
Consolidated Financial Statements |
||||
March 31, 2022 |
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim Cash flows for the period ended March 31 2022 |
||||
|
|
|
|
|
|
Notes |
Mar. 31, 2022 |
|
Mar. 31, 2021 |
|
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Cash flow from operating activities |
|
|
|
|
Profit before income tax from continued operations |
|
6,142,091 |
|
4,088,949 |
Adjustments to reconcile net profit to net cash provided by operating activities |
|
|
|
|
Fixed assets depreciation |
16 |
223,781 |
|
194,609 |
Impairment charge for credit losses (Loans and advances to customers and banks) |
|
(145,266) |
|
720,756 |
Other provisions charges |
21 |
1,036,252 |
|
114,109 |
Impairment charge for credit losses (due from banks) |
|
4,776 |
|
(4,030) |
Impairment (Released) charge for credit losses (financial investments) |
|
101,798 |
|
(14,644) |
Impairment (Released) charge for other assets |
|
(277,768) |
|
12,676 |
Exchange revaluation differences for financial assets at fair value through OCI |
|
63 |
|
23,042 |
Goodwill amortization |
26 |
10,314 |
|
37,819 |
Intangible assets amortization |
27 |
2,591 |
|
9,502 |
Impairment (Released) charge financial assets at fair value through OCI |
|
- |
|
(72,957) |
Utilization of other provisions |
21 |
(156) |
|
(43,518) |
Other provisions no longer used |
21 |
(385) |
|
(5,872) |
Exchange differences of other provisions |
21 |
278,463 |
|
(15,271) |
Profits from selling property and equipment |
|
(50) |
|
(1,250) |
Losses (profits) from selling financial investments |
13 |
(1,040,297) |
|
(420,698) |
Shares based payments |
|
175,235 |
|
162,451 |
Bank's share in the profits of associates |
|
(2,841) |
|
(11,061) |
Operating losses (profits) before changes in operating assets and liabilities |
|
6,508,601 |
|
4,774,612 |
|
|
|
|
|
Net decrease (increase) in assets and liabilities |
|
|
|
|
Due from banks |
|
25,468,271 |
|
(12,278,859) |
Financial assets at fair value through P&L |
13 |
239,339 |
|
18,839 |
Derivative financial instruments |
|
(680,085) |
|
(66,183) |
Loans and advances to banks and customers |
11 - 12 |
(12,821,977) |
|
(2,178,284) |
Other assets |
|
1,844,416 |
|
(371,049) |
Due to banks |
17 |
2,859,939 |
|
(6,304,086) |
Due to customers |
18 |
21,780,515 |
|
25,079,066 |
Income tax obligations paid |
|
(259,516) |
|
(29,046) |
Other liabilities |
|
1,860,904 |
|
(25,774) |
Net cash used in (generated from) operating activities |
|
46,800,407 |
|
8,619,236 |
|
|
|
|
|
Cash flow from investing activities |
|
|
|
|
Proceeds (payments) for investment in associates. |
|
- |
|
(158,360) |
Payment for purchases of property, equipment and branches constructions |
|
(92,999) |
|
(348,974) |
Proceeds from selling property and equipment |
|
50 |
|
1,250 |
Proceeds from redemption of financial assets at amortized cost |
|
2,609,283 |
|
452,910 |
Payment for purchases of financial assets at amortized cost |
|
(2,474,553) |
|
(237,609) |
Payment for purchases of financial assets at fair value through OCI |
|
(68,625,535) |
|
(55,600,830) |
Proceeds from selling financial assets at fair value through OCI |
|
78,456,150 |
|
33,585,657 |
Net cash generated from (used in) investing activities |
|
9,872,396 |
|
(22,305,956) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Condensed Consolidated Interim Cash flows for the period ended March 31, 2022 (Cont.)
|
||||
|
|
|
|
|
|
|
Mar. 31, 2022 |
|
Mar. 31, 2021 |
|
|
EGP Thousands |
|
EGP Thousands |
|
|
|
|
|
Cash flow from financing activities |
|
|
|
|
Received (Repaid) in long term loans |
|
1,035,994 |
|
(14,410) |
Dividend paid |
|
(4,410,322) |
|
(1,360,652) |
Issued debt instruments |
|
253,338 |
|
- |
Capital increase |
|
122,716 |
|
- |
Net cash generated from (used in) financing activities |
|
(2,998,274) |
|
(1,375,062) |
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash and cash equivalent during the priod |
|
53,674,529 |
|
(15,061,782) |
Beginning balance of cash and cash equivalent |
|
61,065,822 |
|
75,796,375 |
Cash and cash equivalent at the end of the period |
|
114,740,351 |
|
60,734,593 |
|
|
|
|
|
Cash and cash equivalent comprise: |
|
|
|
|
Cash and balances at the central bank |
|
30,581,505 |
|
21,800,293 |
Due from banks |
|
121,128,084 |
|
97,518,428 |
Treasury bills and other governmental notes |
10 |
40,379,000 |
|
52,371,207 |
Obligatory reserve balance with CBE |
|
(26,188,639) |
|
(15,805,888) |
Due from banks with maturities more than three months |
|
(10,245,456) |
|
(42,484,048) |
Treasury bills with maturity more than three months |
|
(40,914,143) |
|
(52,665,399) |
Total cash and cash equivalent |
|
114,740,351 |
|
60,734,593 |
'
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2021
|
|
|
|
|
|||||||||||
Mar. 31, 2021 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders' Equity |
Minority Interest |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands |
|
Beginning balance |
14,776,813 |
2,778,135 |
24,765,658 |
1,549,445 |
8,183 |
14,906 |
3,975,514 |
6,423 |
10,539,715 |
1,064,648 |
(3,684) |
59,475,756 |
483,055 |
59,958,811 |
|
Transferred to reserves |
- |
514,939 |
8,420,479 |
- |
- |
1,094 |
- |
- |
(8,936,512) |
- |
- |
- |
- |
- |
|
Dividend paid |
- |
- |
- |
- |
- |
- |
- |
- |
(1,360,652) |
- |
- |
(1,360,652) |
- |
(1,360,652) |
|
Net profit of the year |
- |
- |
- |
- |
- |
- |
- |
- |
2,873,044 |
- |
- |
2,873,044 |
419 |
2,873,463 |
|
Transferred from reserve of financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(104,406) |
- |
104,406 |
- |
- |
- |
- |
- |
|
Transferred from previous years' outstanding balances |
- |
- |
- |
- |
- |
- |
- |
- |
8,333 |
- |
- |
8,333 |
- |
8,333 |
|
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
- |
(1,674,309) |
- |
- |
- |
- |
(1,674,309) |
- |
(1,674,309) |
|
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
2,718 |
(2,718) |
- |
- |
- |
- |
- |
|
ECL for impairment of debt instruments investments |
- |
- |
- |
- |
- |
- |
(14,644) |
- |
- |
- |
- |
(14,644) |
- |
(14,644) |
|
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
162,451 |
- |
162,451 |
- |
162,451 |
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
364 |
364 |
- |
364 |
|
Balance at the end of the period |
14,776,813 |
3,293,074 |
33,186,137 |
1,549,445 |
8,183 |
16,000 |
2,182,155 |
9,141 |
3,225,616 |
1,227,099 |
(3,320) |
59,470,343 |
483,474 |
59,953,817 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Interim statement of changes in shareholders' equity for the period ended March 31, 2022
|
|
|
|
|
|||||||||||
|
|
|
|
|
|||||||||||
Mar. 31, 2022 |
Issued and paid up capital |
Legal reserve |
General reserve |
General risk reserve |
Reserve for transactions under common control |
Capital reserve |
Reserve for financial assets at fair value through OCI |
Banking risks reserve |
Retained earnings |
Reserve for employee stock ownership plan |
Cumulative foreign currencies translation differences |
Total Shareholders' Equity |
Minority Interest |
Total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EGP Thousands |
|
Beginning balance |
19,702,418 |
3,293,074 |
28,260,532 |
1,550,906 |
8,183 |
16,000 |
641,372 |
9,141 |
13,696,402 |
1,674,392 |
(4,218) |
68,848,202 |
454,535 |
69,302,737 |
|
Capital increase |
122,716 |
- |
502,922 |
- |
- |
- |
- |
- |
- |
(502,922) |
- |
122,716 |
- |
122,716 |
|
Transferred to reserves |
- |
670,872 |
8,333,404 |
- |
- |
2,947 |
- |
- |
(9,007,223) |
- |
- |
- |
- |
- |
|
Dividend paid |
- |
- |
- |
- |
- |
- |
- |
- |
(4,410,322) |
- |
- |
(4,410,322) |
- |
(4,410,322) |
|
Net profit of the year |
- |
- |
- |
- |
- |
- |
- |
- |
4,244,231 |
- |
- |
4,244,231 |
15,387 |
4,259,618 |
|
Transferred from reserve on disposal of financial assets at fair value through OCI |
- |
- |
- |
- |
- |
- |
(4,201) |
- |
4,201 |
- |
- |
- |
- |
- |
|
Net unrealised gain/(loss) on financial assets at fair value through OCI after tax |
- |
- |
- |
- |
- |
- |
(3,961,167) |
- |
- |
- |
- |
(3,961,167) |
- |
(3,961,167) |
|
Transferred (from) to banking risk reserve |
- |
- |
- |
- |
- |
- |
- |
2,840 |
(2,840) |
- |
- |
- |
- |
- |
|
Effect of ECL in fair value of debt instruments measured at fair value through OCI |
- |
- |
- |
- |
- |
- |
101,602 |
- |
- |
- |
- |
101,602 |
- |
101,602 |
|
Cost of employees stock ownership plan (ESOP) |
- |
- |
- |
- |
- |
- |
- |
- |
- |
175,235 |
- |
175,235 |
- |
175,235 |
|
Cumulative foreign currencies translation differences |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
56,854 |
56,854 |
39,279 |
96,133 |
|
Balance at the end of the period |
19,825,134 |
3,963,946 |
37,096,858 |
1,550,906 |
8,183 |
18,947 |
(3,222,394) |
11,981 |
4,524,449 |
1,346,705 |
52,636 |
65,177,351 |
509,201 |
65,686,552 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|